A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis (MS) are decreased, with an increased risk of relapse in the first months postpartum. This systematic review evaluated relapses during pregnancy and postpartum, according to disease-modifying therapy (DMT) exp...
Guardado en:
Autores principales: | Kerstin Hellwig, Elisabetta Verdun di Cantogno, Meritxell Sabidó |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7d6f9d4b983426f9486c0cb22ee7040 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi A, et al.
Publicado: (2013) -
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Sandra Thiel, et al.
Publicado: (2021) -
Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey D, et al.
Publicado: (2015) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: Fabricio González-Andrade, et al.
Publicado: (2010) -
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
por: Julie A Murphy, et al.
Publicado: (2010)